For World Asthma Day, GINA released its 2025 guidelines update and joined in a campaign to make inhaled asthma therapies more ...

Pulmatrix, Inc. ("Pulmatrix" or the "Company") , a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and ...

Expect to report topline data from the Seabreeze STAT COPD study in 1H 2026 – SAN DIEGO, May 14, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma, Connect ...

A new study reanalyzing spirometry data in Northeast Asian COPD patients suggests that race-neutral GLI reference equations ...

Mucus plugs affect some 40% to nearly 70% of COPD patients, and even clinically silent mucus plugs are linked to poorer ...

Cardiac intensive care units are witnessing a demographic shift, characterized by patients with increasingly complex or ...

Registration statement for proposed Cullgen merger declared effective by the SEC Proposed merger anticipated to close in June As part of proposed merger, Pulmatrix ...